Sfoglia per Autore
Low-Dose Lenalidomide Improves CAR-Based Immunotherapy In CLL By Reverting T-Cell Defects In Vivo
2013 Bertilaccio, M; Tettamanti, S; Attianese, G; Galletti, G; Arcangeli, S; Rodriguez, T; Magnani, C; Barbaglio, F; Scarfò, L; Ponzoni, M; Biondi, A; Caligaris Cappio, F; Biagi, E; Ghia, P
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives
2013 Magnani, C; Tettamanti, S; Maltese, F; Turazzi, N; Biondi, A; Biagi, E
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor
2013 Tettamanti, S; Marin, V; Pizzitola, I; Magnani, C; GIORDANO ATTIANESE, G; Cribioli, E; Maltese, F; Galimberti, S; Lopez, A; Biondi, A; Bonnet, D; Biagi, E
Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis
2013 Belingheri, M; Lazzari, L; Parazzi, V; Groppali, E; Biagi, E; Gaipa, G; Giordano, R; Rastaldi, M; Croci, D; Biondi, A; Rebulla, P; Edefonti, A; Ghio, L
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells
2013 Magnani, C; Turazzi, N; Benedicenti, F; Attianese, G; Tettamanti, S; Montini, E; Cooper, L; Aiuti, A; Biondi, A; Biagi, E
Upregulation of Adhesion Molecules on Leukemia Targets Improves the Efficacy of Cytotoxic T Cells Transduced With Chimeric Anti-CD19 Receptor
2013 Laurin, D; Marin, V; Biagi, E; Pizzitola, I; Agostoni, V; Gallot, G; Vié, H; Christine Jacob, M; Chaperot, L; Aspord, C; Plumas, J
Mesenchymal stem/stromal cells: a new "cells as drugs" paradigm. Efficacy and critical aspects in cell therapy
2013 de Girolamo, L; Lucarelli, E; Alessandri, G; Avanzini, M; Bernardo, M; Biagi, E; Brini, A; D'Amico, G; Fagioli, F; Ferrero, I; Locatelli, F; Maccario, R; Marazzi, M; Parolini, O; Pessina, A; Torre, M
Acute myeloid leukemia and novel biological treatments: Monoclonal antibodies and cell-based gene-modified immune effectors
2013 Tettamanti, S; Magnani, C; Biondi, A; Biagi, E
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring
2012 Dander, E; Lucchini, G; Vinci, P; Introna, M; Masciocchi, F; Perseghin, P; Balduzzi, A; Bonanomi, S; Longoni, D; Gaipa, G; Belotti, D; Parma, M; Algarotti, A; Capelli, C; Golay, J; Rovelli, A; Rambaldi, A; Biondi, A; Biagi, E; D'Amico, G
LONG TERM SURVIVAL AND EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT DEPENDENT ON IMMUNOSUPPRESSIVE TREATMENT.
2012 Pischiutta, F; Zanier, E; D'Amico, G; Dander, E; Gaipa, G; Biondi, A; Biagi, E; Citerio, G; De Simoni, M
Basic biology and clinical application of multipotent mesenchymal stromal cells: from bench to bedside
2012 Kuçi, S; Henschler, R; Müller, I; Biagi, E; Meisel, R
LONG TERM EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT AFFECTED BY IMMUNOSUPPRESSIVE TREATMENT.
2012 Pischiutta, F; Zanier, E; D'Amico, G; Marchesi, F; Biondi, A; Biagi, E; Citerio, G; De Simoni, M
LONG TERM EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT AFFECTED BY IMMUNOSUPPRESSIVE TREATMENT.
2012 Zanier, E; Pischiuta, F; Giovanna, D; Bionfi, A; Biagi, E; Citerio, G; De Simoni, M
Long term efficacy of human bone marrow mesenchymal stem cells in traumatized mice brain is not affected by immunosuppressive treatment
2012 Pischiutta, F; Zanier, E; D'Amico, G; Marchesi, F; Biondi, A; Biagi, E; Citerio, G; De Simoni, M
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients
2012 Introna, M; Lucchini, G; Dander, E; Rovelli, A; Balduzzi, A; Longoni, D; Pavan, F; Masciochi, F; Algarotti, A; Micò, C; Grassi, A; Cavattoni, I; Deola, S; Gaipa, G; Belotti, D; Perseghin, P; Parma, M; Pogliani, E; Golay, J; Gotti, E; Capelli, C; Cortelazzo, S; D'Amico, G; Biondi, A; Rambaldi, A; Biagi, E
Comparison of different suicide-gene strategies for the safety improvement of genetically manipulated T cells
2012 Marin, V; Cribioli, E; Philip, B; Tettamanti, S; Pizzitola, I; Biondi, A; Biagi, E; Pule, M
Chimeric Antigen Receptor for Specific Targeting of Acute Myeloid Leukemia
2012 Pizzitola, I; Anjos Afonso, F; Rouault Pierre, K; Lassailly, F; Tettamanti, S; Biondi, A; Biagi, E; Bonnet, D
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation
2012 Lucchini, G; Dander, E; Pavan, F; Di Ceglie, I; Balduzzi, A; Perseghin, P; Gaipa, G; Algarotti, A; Introna, M; Rambaldi, A; Rovelli, A; Biondi, A; Biagi, E; D'Amico, G
From Bone Marrow Transplantation to Cellular Therapies: Possible therapeutic strategies in managing autoimmune disorders
2012 Taddio, A; Biondi, A; Piscianz, E; Valencic, E; Biagi, E; Badolato, R
Targeting of Acute Myeloid Leukemia by Cytokine-Induced Killer Cells Redirected with a Novel CD123-Specific Chimeric Antigen Receptor
2012 Tettamanti, S; Marin, V; Pizzitola, I; Magnani, C; Attianese, G; Cribioli, E; Lopez, A; Biondi, A; Bonnet, D; Biagi, E
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile